P2RY12 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

N° du produit ABIN2728089

Détail du produit

Antigène: P2RY12 (Purinergic Receptor P2Y, G-Protein Coupled, 12 (P2RY12))

Type de proteíne: Recombinant

Attributs du protein: Transcript Variant 1

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette P2RY12 protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human P2RY12 / P2Y12 (transcript variant 1) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: P2RY12 (Purinergic Receptor P2Y, G-Protein Coupled, 12 (P2RY12))

Autre désignation: p2ry12,p2y12 (P2RY12 Produits)

Synonymes: 2900079B22Rik Protein, 4921504D23Rik Protein, P2Y12 Protein, ADPG-R Protein, BDPLT8 Protein, HORK3 Protein, P2T(AC) Protein, P2Y(12)R Protein, P2Y(AC) Protein, P2Y(ADP) Protein, P2Y(cyc) Protein, SP1999 Protein, P2y12 Protein, purinergic receptor P2Y, G-protein coupled 12 Protein, purinergic receptor P2Y12 Protein, P2ry12 Protein, P2RY12 Protein

Sujet: The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene.

Poids moléculaire: 39.3 kDa

NCBI Accession: NP_073625